M
Michiya Kawaguchi
Researcher at Kyoto University
Publications - 23
Citations - 2058
Michiya Kawaguchi is an academic researcher from Kyoto University. The author has contributed to research in topics: Pancreas & Pancreatic cancer. The author has an hindex of 13, co-authored 23 publications receiving 1930 citations.
Papers
More filters
Journal ArticleDOI
Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine
Kenichiro Furuyama,Yoshiya Kawaguchi,Haruhiko Akiyama,Masashi Horiguchi,S. Kodama,T. Kuhara,Shinichi Hosokawa,Ashraf Elbahrawy,Tsunemitsu Soeda,Masayuki Koizumi,Toshihiko Masui,Michiya Kawaguchi,Kyoichi Takaori,Ryuichiro Doi,Eiichiro Nishi,Ryosuke Kakinoki,Jian Min Deng,Richard R. Behringer,Takashi Nakamura,Shinji Uemoto +19 more
TL;DR: It is shown that Sox9 is expressed throughout the biliary and pancreatic ductal epithelia, which are connected to the intestinal stem-cell zone, which suggests interdependence between the structure and homeostasis of endodermal organs, with Sox9 expression being linked to progenitor status.
Journal Article
Expression of Stromal Cell-derived Factor 1 and CXCR4 Ligand Receptor System in Pancreatic Cancer: A Possible Role for Tumor Progression
Takatomo Koshiba,Ryo Hosotani,Yoshiharu Miyamoto,Jun Ida,Shoichiro Tsuji,Sanae Nakajima,Michiya Kawaguchi,Hiroyuki Kobayashi,Ryuichiro Doi,Toshiyuki Hori,Nobutaka Fujii,Masayuki Imamura +11 more
TL;DR: In vitro studies demonstrated that SDF-1 significantly increased the migration ability of AsPC-1 and HUVECs, and these effects were inhibited by CXCR4 antagonist T22, and that the coculture system with MRC-9 also increased the Migration ability of CFPAC-1 cells, and this effect was significantly inhibited by T22.
Journal ArticleDOI
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
Masashi Kanai,Yoshihiko Otsuka,Kazunori Otsuka,Maremi Sato,Takafumi Nishimura,Yukiko Mori,Michiya Kawaguchi,Etsuro Hatano,Yuzo Kodama,Shigemi Matsumoto,Yoshiki Murakami,Atsushi Imaizumi,Tsutomu Chiba,Jun Nishihira,Hiroyuki Shibata +14 more
TL;DR: Repetitive systemic exposure to high concentrations of curcumin achieved by Theracurmin® did not increase the incidence of adverse events in cancer patients receiving gemcitabine-based chemotherapy.
Journal ArticleDOI
Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis.
Ryo Hosotani,Michiya Kawaguchi,Toshihiko Masui,Takatomo Koshiba,Jyun Ida,Koji Fujimoto,Michihiko Wada,Ryuichiro Doi,Masayuki Imamura +8 more
TL;DR: Examining expression analysis in pancreatic cancer tissue demonstrated involvement of alphaVbeta3 integrin in lymph node metastasis rather than peripancreatic invasion, and MMP-2 activation is linked, at least in part, to the expression of integrin alphaV beta3 of pancreaticcancer cells.
Journal ArticleDOI
Expression of METH-1 and METH-2 in pancreatic cancer
Toshihiko Masui,Shoichiro Tuji,Jun Ida,Sanae Nakajima,Michiya Kawaguchi,Masayuki Koizumi,Eiji Toyoda,Shidhartha Tulachan,Seichi Yasuda,Ryo Hosotani,Ryuichiro Doi,Masayuki Imamura +11 more
TL;DR: METH-1, which was initially reported to have a potent antiangiogenic effect, does not seem to be a predominant determinant of tumor vascularity in pancreatic cancer, and rather seems to be involved in progression of pancreaticcancer through local invasion and lymph node metastasis.